Navigation Links
New Treatment For Headache

Thirteen years ago, Eric Phillips who was on his way to becoming a lawyer says how a single flight of stairs changed everything. // “The top step had ice, and I went straight over backwards," he says. "I wasn’t found for three hours, and when they found me, I had blood coming out of my ears and my nose. I don’t have a personal recollection for two and a half years after that moment. ”Eric suffered a massive head injury. "My pain just got worse and worse, until I couldn’t stand it. I mean, it was so sharp, I didn’t know what to do. It was really hard to deal with life,” he says.

Most people know the pain of a headache, but for many, the symptoms come and go or are short-lived. But, there are some people who have constant, chronic headache pain that simply does not respond to standard therapy. Often brought on by a traumatic head injury or after brain surgery, there has been little to offer these patients, until now.

The answer to Eric’s pain and headaches came from a pain specialist at RUSH University Medical Center in Chicago. To relieve the pain, electrodes were connected to nerves that exit the brain. An implanted battery then sends signals through the neck to turn off the pain. Specialists say , each nerve has a positive and negative charge to it, and by stimulating those nerves, you can kind of reverse the polarity of the nerves. In patients who are good responders, this is a lifesaver. “It’s given me a whole new life," Eric says. "I feel like I started all over.”

However specialists say this procedure is not meant for patients who have headaches for just a few months. It’s for patients who have had headaches for years and have been resilient to conventional treaments.
'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is ... natural lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO ... to create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... ... December 05, 2016 , ... The ... care facility – Avamere Transitional Care of Puget Sound ; located at ... health care center will provide patients recovering from illness or injury with intensive ...
(Date:12/5/2016)... VA (PRWEB) , ... December 05, 2016 , ... ... today announced it has been featured in SuperbCrew magazine, a leading online tech ... tech world. This interview, now featured on SuperbCrew.com, explores the state of enterprise ...
(Date:12/5/2016)... ... ... Researchers at Johns Hopkins All Children’s Hospital want to learn more about ... of three years, researchers will study concussions and changes in brain function by monitoring ... sensors, will track the location and force of the hit. The sensors store data ...
(Date:12/5/2016)... ... December 05, 2016 , ... “Epilepsy ... through tomorrow, December 6th, sparks a conversation about epilepsy, bearing down on the ... 26 people will be diagnosed with epilepsy within their lifetime. With such a ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Sanovas, Inc., a life science asset holding ... its wholly owned subsidiary, Intubation Science, Inc., and its LightSpeed ... - http://photos.prnewswire.com/prnh/20161202/445251LOGO   ... Sanovas, Inc. ... There are over 40 million Endotracheal Intubations performed ...
(Date:12/5/2016)... 2016  CVS Health, the nation,s largest pharmacy innovation ... score of 100 percent on the Corporate Equality Index ... an annual national benchmarking survey and report on corporate ... the Human Rights Campaign Foundation. "Our ... colleagues, customers and suppliers bring to CVS Health," said ...
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 /PRNewswire/ ... announced preliminary safety and efficacy data from a ... selective MDM2 inhibitor, suggesting that DS-3032 may be ... acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome ... of the phase 1 study of DS-3032 were presented ...
Breaking Medicine Technology: